These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features. El-Zammar OA; Zhang S; Katzenstein AL Diagn Mol Pathol; 2009 Sep; 18(3):133-7. PubMed ID: 19704257 [TBL] [Abstract][Full Text] [Related]
7. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization. Dancer J; Takei H; Ro JY; Lowery-Nordberg M Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma. Buckley AF; Burgart LJ; Kakar S Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914 [TBL] [Abstract][Full Text] [Related]
9. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study. Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203 [TBL] [Abstract][Full Text] [Related]
10. Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma. Lee J; Jang KT; Ki CS; Lim T; Park YS; Lim HY; Choi DW; Kang WK; Park K; Park JO Cancer; 2007 Apr; 109(8):1561-9. PubMed ID: 17354229 [TBL] [Abstract][Full Text] [Related]
11. Correlation of epidermal growth factor receptor mutation, immunohistochemistry, and fluorescence in situ hybridization in esophageal squamous cell carcinoma. Sunpaweravong P; Suwiwat S; Sunpaweravong S; Puttawibul P; Mitarnun W J Med Assoc Thai; 2009 Sep; 92(9):1136-42. PubMed ID: 19772171 [TBL] [Abstract][Full Text] [Related]
12. EGFRvIII mutation in lung cancer correlates with increased EGFR copy number. Sasaki H; Kawano O; Endo K; Yukiue H; Yano M; Fujii Y Oncol Rep; 2007 Feb; 17(2):319-23. PubMed ID: 17203167 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890 [TBL] [Abstract][Full Text] [Related]
14. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533 [TBL] [Abstract][Full Text] [Related]
15. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers. Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor mutations in small cell lung cancer. Tatematsu A; Shimizu J; Murakami Y; Horio Y; Nakamura S; Hida T; Mitsudomi T; Yatabe Y Clin Cancer Res; 2008 Oct; 14(19):6092-6. PubMed ID: 18829487 [TBL] [Abstract][Full Text] [Related]
18. EGFR gene and protein expression in breast cancers. Park K; Han S; Shin E; Kim HJ; Kim JY Eur J Surg Oncol; 2007 Oct; 33(8):956-60. PubMed ID: 17374474 [TBL] [Abstract][Full Text] [Related]
19. Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Ionescu DN; Sasatomi E; Cieply K; Nola M; Dacic S Cancer; 2005 Feb; 103(3):630-6. PubMed ID: 15630697 [TBL] [Abstract][Full Text] [Related]
20. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer. Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]